United States · FDA National Drug Code directory
Olanzapine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65862-561_e10b90de-4a0a-413e-a5f9-6978a183b568
- Product NDC
- 65862-561
- Form
- TABLET
- Composition / generic term
- Olanzapine
- Labeler
- Aurobindo Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20120423
- Source listing expiry
- 20271231
Source-listed ingredients
- OLANZAPINE — 2.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (65862-561-01) · 65862-561-01
- 10 BLISTER PACK in 1 CARTON (65862-561-10) / 10 TABLET in 1 BLISTER PACK · 65862-561-10
- 30 TABLET in 1 BOTTLE (65862-561-30) · 65862-561-30
- 1000 TABLET in 1 BOTTLE (65862-561-99) · 65862-561-99
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →